Anduril valuation 2026: how much is Anduril worth?
Anduril is worth $86.5B as of June 2026 — its current valuation on the NPM Price (Nasdaq Private Market), 16% below its last round (Series H, $103B). That is Anduril's latest private-market valuation; it has no public stock price.
Per-share → stock price · over time → valuation history.
What could Anduril be worth by the end of 2026?
Prediction markets put Anduril's even-odds 2026 valuation at $67B (indicative) — 22% below today's $86.5B. The middle 50% of outcomes runs $65B–$177B.
Indicative: this market is coarsely priced, so we show the central estimate and its range rather than a precise per-level ladder.
Worth now → valuation · what it might IPO at → IPO odds.
When will Anduril IPO?
Anduril has not IPO'd and is not publicly traded — it's private, with no ticker. The market implies ~9% odds Anduril has gone public by year-end.
Prediction-market odds, not Anduril guidance.
Current value → valuation · convert to per-share → stock price.
What is Anduril's stock price?
Anduril is private, so it has no public stock price. Its secondary share price is $117/share (pre-IPO, as of 22 Jun 2026), and $98/share at the $86.5B NPM valuation mark (as of 18 Jun 2026).
Divides each valuation by ~0.88B estimated diluted shares (Anduril is private; the exact count isn't disclosed). An IPO issues new shares, diluting existing holdings. An estimate, not advice or an appraisal.
Valuation over time → valuation history.
Anduril valuation history: how has it changed?
Anduril's valuation has gone from $39B (Jun 2025) to $86B (Jun 2026) — 2.2× (+121%) in 12 months. The sharpest step came at the Series H round in May 2026.
| Date | NPM valuation |
|---|---|
| Jun 2025 | $39B |
| Sep 2025 | $46B |
| Dec 2025 | $60B |
| Mar 2026 | $71B |
| Jun 2026 | $86B |
Current value → valuation · per-share → stock price.
Who owns Anduril?
Anduril is privately owned by its founders and employees plus its investors — led by 137 Ventures, which led its Series H round — and by 9 regulated mutual funds that independently mark its shares at $63.74 in SEC filings. Its funding is entirely private capital: $12B across 10 funding rounds, and it is not publicly traded.
Round lead 137 Ventures
Fund holders BlackRock · Fidelity · Franklin Templeton
Why $63.74, below the ~$117 secondary price? Funds carry earlier-series preferred near its issue price, not the current common stock that trades on secondaries — a more conservative, independent mark.
Show the underlying fund filings (9 funds · 28 marks)
| Fund (filer) | Series held | Period | Per share |
|---|---|---|---|
| Blackrock Science & Technology Trust (bst) | F / G | 2026-12-31 | $63.74 |
| Franklin Strategic Series | B / C / G | 2026-04-30 | $63.74 |
| Fidelity Advisor Series I | B / C / F / G | 2026-11-30 | $63.74 |
| Variable Insurance Products Fund | B / C / F / G | 2026-12-31 | $63.74 |
| Fidelity Mt Vernon Street Trust | B / C / G | 2026-11-30 | $63.74 |
| Fidelity Destiny Portfolios | B / C / G | 2026-09-30 | $63.74 |
| Fidelity Hastings Street Trust | B / C / G | 2026-06-30 | $63.74 |
| Fidelity Puritan Trust | B / C / G | 2026-08-31 | $63.74 |
| Variable Insurance Products Fund III | B / F / G | 2026-12-31 | $63.74 |
Mark vs live valuation → valuation · per-share → stock price.
Can you buy Anduril stock?
No — you can't buy Anduril stock on a normal brokerage: it's private, with no ticker. How to invest in Anduril directly is limited to accredited investors, via restricted pre-IPO secondaries ($117/share). The one route open to anyone — no broker, no accreditation — is a prediction market on Anduril's valuation.
Bet YES on “Anduril ≥ $65B by Dec 31, 2026” at 46¢ and make ≈ +117% if it hits (full odds ladder →). Or back the IPO itself — 9% listed by year-end (IPO odds →).
A prediction-market bet is binary, not equity: a fixed $1 if it hits the strike by the date, $0 if not. Availability varies by region.
Latest on Anduril
What recently moved the valuation and IPO odds, plus headlines — newest first.
- 23 Jun 2026 Market-implied odds of an IPO by year-end at 9%. Polymarket / Kalshi
- 23 Jun 2026 Odds of reaching $75B by year-end at 45%. -39 pts in a month Polymarket
- 18 Jun 2026 Anduril's valuation marked at $86.5B. +4% over ~30 days · NPM Price (Nasdaq Private Market) NPM
- 13 May 2026 Series H closes — $5.0B raised, led by 137 Ventures. post-money $103B Yahoo Finance / Forge
- 22 Jun 2026 Investment Adviser Hit With SEC Suit Over Anduril Stock Scheme Bloomberg Law News
- 22 Jun 2026 Anduril in talks with Israeli officials to establish local defense-tech hub The Jerusalem Post
- 21 Jun 2026
- 21 Jun 2026
- 16 Jun 2026
Common questions about Anduril stock
Is Anduril publicly traded?
Can you buy Anduril stock, or is it on Robinhood?
How much is Anduril worth?
Who owns Anduril?
Does Anduril pay a dividend?
Sources & method
Every figure is sourced below, each with its own timestamp. See the methodology for how each is computed.
An estimate, not an appraisal or investment advice. Anduril is private; its shares are unregistered and secondary transfers may be restricted. Figures aggregate public filings and licensed third-party data, attributed above. Moonberg doesn't broker, sell, or hold any security.